FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to nephrology and refers to using a combination of metabolites containing at least two amino acids, at least two acylcarnitines and at least two biogenic amines as a biomarker array aiming at assessing a chronic renal disease in a blood sample. There are also presented a method and a set of biomarkers for assessing the chronic renal disease in a mammal.
EFFECT: group of inventions provides the accurate and early diagnosis of renal diseases by studying the above specific biomarkers in the blood sample taken from the patient.
9 cl, 14 dwg, 27 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING AND TREATING OR PREVENTING DISTURBED LEVELS OF POLAR LIPIDS IN PLASMA | 2015 |
|
RU2705208C2 |
| NUTRITIONAL COMPOSITION AND INFANT FORMULA FOR STIMULATING PRIMARY MYELINATION | 2016 |
|
RU2766598C2 |
| COMPOSITIONS AND THEIR USE | 2016 |
|
RU2793427C2 |
| NUTRITIONAL COMPOSITION AND INFANT FORMULA FOR STIMULATION OF BRAIN MYELINIZATION | 2016 |
|
RU2795441C2 |
| NUTRITIONAL COMPOSITIONS AND INFANT FORMULAS THAT PROMOTE PRIMARY MYELINATION | 2016 |
|
RU2766014C2 |
| NUTRITIONAL COMPOSITION AND INFANT FORMULA FOR STIMULATING BRAIN MYELINATION | 2016 |
|
RU2766208C2 |
| HYDRONOPOLE DERIVATIVES AS AGONISTS TO ORL1 HUMAN RECEPTORS | 2004 |
|
RU2351600C2 |
| ANTISENSE OLIGONUCLEOTIDES TO HIF-1-ALPHA | 2017 |
|
RU2753517C2 |
| ANTISENSE TYROSINASE OLIGONUCLEOTIDES | 2018 |
|
RU2778786C2 |
